TRIM5α: A Protean Architect of Viral Recognition and Innate Immunity
Viruses · 21.06.2024 · 16 (7) · 997
DOI: 10.3390/v16070997 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 21.06.2024. Verfasst von Stephanie J Spada und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Structural Biology, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK. Hauptthemen laut MEDLINE: Immunity, Innate, Retroviridae, Tripartite Motif Proteins, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, ERC, NIH HHS.
Abstract (Originalsprache)
The evolutionary pressures exerted by viral infections have led to the development of various cellular proteins with potent antiviral activities, some of which are known as antiviral restriction factors. TRIpartite Motif-containing protein 5 alpha (TRIM5α) is a well-studied restriction factor of retroviruses that exhibits virus- and host-species-specific functions in protecting against cross-primate transmission of specific lentiviruses. This specificity is achieved at the level of the host gene through positive selection predominantly within its C-terminal B30.2/PRYSPRY domain, which is responsible for the highly specific recognition of retroviral capsids. However, more recent work has challenged this paradigm, demonstrating TRIM5α as a restriction factor for retroelements as well as phylogenetically distinct viral families, acting similarly through the recognition of viral gene products via B30.2/PRYSPRY. This spectrum of antiviral activity raises questions regarding the genetic and structural plasticity of this protein as a mediator of the recognition of a potentially diverse array of viral molecular patterns. This review highlights the dynamic evolutionary footprint of the B30.2/PRYSPRY domain in response to retroviruses while exploring the guided ‘specificity’ conferred by the totality of TRIM5α’s additional domains that may account for its recently identified promiscuity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Structural Biology, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
- Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD 20894, USA.
- Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, MT 59840, USA.
- Diamond Light Source, Harwell Science and Innovation Campus, Didcot OX11 0DE, UK.
- Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford OX3 7BN, UK.
ORCID-Profile: Peijun Zhang
Förderung
- NIAID NIH HHS
- ERC
- NIH HHS
- Wellcome Trust Investigator Award
- Wellcome Trust
- NIH
- NIH-OxCam DPhil program
Zitieren
APA
Spada, S. J., Grigg, M. E., Bouamr, F., Best, S. M., & Zhang, P. (2024). TRIM5α: A Protean Architect of Viral Recognition and Innate Immunity. Viruses, 16(7), 997. https://doi.org/10.3390/v16070997
Vancouver
Spada SJ, Grigg ME, Bouamr F, Best SM, Zhang P. TRIM5α: A Protean Architect of Viral Recognition and Innate Immunity. Viruses. 2024;16(7):997. doi:10.3390/v16070997
BibTeX
@article{Spada2024,
author = {Spada, Stephanie J and Grigg, Michael E and Bouamr, Fadila and Best, Sonja M and Zhang, Peijun},
title = {TRIM5α: A Protean Architect of Viral Recognition and Innate Immunity},
journal = {Viruses},
year = {2024},
volume = {16},
number = {7},
pages = {997},
doi = {10.3390/v16070997}
}
EUVIMED